http://www.aneki.com/melanoma_cancer_countries.html

Australia and New Zealand have the highest incidences of melanoma - more than double the US. 1 Billion people in China and another 1 Billion in India. Only 317 Million people in the US...seems silly to think that there are no options. I think that if this company was smart, I would open an office in Sydney ASAP!

During the conference call the main point they made was that is in the FDA letter, the FDA wanted them to show they fixed symptoms - pain, bleeding etc. Provectus designed the study to CURE cancer, NOT treat pain, so didn't have much data on side of symptoms. Common sense would say curing cancer is better, but they couldn't convince the FDA of that because the FDA refuses to accept any "drug" that actually CURES cancer. Which is why on Dr. Carl June's therapy may actually come to fruition - because it is gene therapy to cure cancers. IMO and from my years of biotech industry experience, this is typical of the big business drug industry. Don't cure the disease, find a drug to treat it and make it feel better, so u can sell it for life and make more $. I don't think there was any wrong doing, incompetence or negligible action on the part of Provectus.

If this drops to .25 I am going to buy half a million shares @ that PPS. Guys...what has really changed? I will ask it again. Does anyone really believe that an FDA BTD approval was built into this PPS even at $3.30? I submit NO! If it were the PPS would have been north of $8 or more. Who actually thought it would happen when 1 of 12 were approved last year.

Do any of you actually believe that the approval was built into PPS @ $2.09? So realistically, what has changed? 1 of 12 BTDs was approved last year. If you know anything about pharma and biotech, the company is no different today than it was yesterday. I do not believe that the current PPS was a product of an assumed approval. JMHO.

DM me on twitter if you want to chat about it @changeagent21

Believe me! I want it to be the other way but I am mentally preparing myself for what each passing moment is making more clear.

They clearly did not get the approval for BTD and the NYSE and SEC are assessing the damage to PPS and whether the impact can put their NYSE listing at danger. It is kind of a PR nightmare to have a company ring the opening bell and be delisted a day later. Hence the halt...if it were an approval, we would all be basking in the glory by now.

I am a shareholder...

Agree! But also think that the MINE sell-off was premature, as evidence by the bounce back Thursday and Friday. Don't think people understand the true potential in specialty food/energy market - especially all-natural. The Maveron presence should speak volumes.

CEO of $BRND

Seems like a real company to me... https://touch.www.linkedin.com/?sessionid=19257461047296&as=false&can=http%253A%252F%252Fwww.linkedin.com%252Fpub%252Fmichael-shea%252F7%252F550%252F72&rs=false&dl=no#profile/22249814/

FYI, should stop overhyping Sanjay Gupta pick-up, it was a result of good PR and SEO, they mentioned his name in the press release, webcrawlers picked it up. It isn't like SJG went out endorsing the company.